Assisted Reproductive Technology Market Trends, Opportunities, Overview By 2033

Overview and Scope
Assisted reproductive technology is based on the surgical removal of eggs from women’s ovaries and then fusing them with men’s sperm in the laboratory to create embryos. These embryos are then inserted back into the woman’s body. ART uses donor eggs, donor sperm, or previously stored frozen embryos. Assisted reproductive technology (ART) is used for the treatment of infertility in either eggs or embryos.

Sizing and Forecast
The assisted reproductive technology market size has grown rapidly in recent years. It will grow from $38.04 billion in 2023 to $45.42 billion in 2024 at a compound annual growth rate (CAGR) of 19.4%.  The growth in the historic period can be attributed to increase in infertility rates, changing societal norms, growing awareness, legislative support, aging population.

The assisted reproductive technology market size is expected to see rapid growth in the next few years. It will grow to $91.8 billion in 2028 at a compound annual growth rate (CAGR) of 19.2%.  The growth in the forecast period can be attributed to increasing maternal age, rising demand for same-sex parenting, medical tourism, expanding healthcare infrastructure, research and development. Major trends in the forecast period include use of artificial intelligence (ai), egg freezing, single-embryo transfer (set), pgt-a and genetic screening, innovative fertility preservation techniques.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Segmentation & Regional Insights
The assisted reproductive technology market covered in this report is segmented –
1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Europe was the largest region in the assisted reproductive technology market in 2023. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Major Driver Impacting Market Growth
The rising number of infertility cases is expected to foster the assisted reproductive technology market in the coming years. Infertility is defined as the failure to become pregnant after a year of frequent and unprotected intercourse. Infertility affects both men and women, and is typically diagnosed by the inability to conceive. Infertility is treated using assisted reproductive technology (ART). Fertility therapies that work with both a woman’s egg and a man’s sperm are included in this. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based international public health organization, millions of people in the world who are of reproductive age will struggle with infertility, which will also influence their families and communities. Worldwide, it is estimated that 1 in 6 adults or around 17.5% of the global adult population struggle with infertility. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market.

Key Industry Players
Major companies operating in the assisted reproductive technology market include  Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

The assisted reproductive technology market report table of contents includes:
            1. Executive Summary

2. Assisted Reproductive Technology Market Characteristics
3. Assisted Reproductive Technology Market Trends And Strategies
4. Assisted Reproductive Technology Market – Macro Economic Scenario
5. Global Assisted Reproductive Technology Market Size and Growth
6. Assisted Reproductive Technology Market Segmentation
7. Assisted Reproductive Technology Market Regional And Country Analysis

…………..

33. Key Mergers And Acquisitions In The Assisted Reproductive Technology Market
34. Assisted Reproductive Technology Market Future Outlook and Potential Analysis
35. Appendix

 

List Of Tables : 

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

……………

Table 74: Cooper Surgical Inc. Financial Performance

Table 75: Ferring Pharmaceuticals Ltd. Financial Performance

Table 76: Hamilton Thorne Ltd. Financial Performance

Table 77: Merck KGaA Financial Performance

Table 78: Genea Limited Financial Performance

Explore the trending research reports from TBRC:

https://topprnews.com/temporary-shelters-market-trends/

https://goodprnews.com/social-assistance-market-trends/

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model